4DMedical Limited (4DX.AX)
AUD 0.38
(-1.32%)
AUD 0.38
(-1.32%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 | 120.01 Million AUD | 29.16% |
| 2023 | 92.92 Million AUD | 25.04% |
| 2022 | 74.31 Million AUD | -19.78% |
| 2021 | 92.63 Million AUD | 485.4% |
| 2020 | 15.82 Million AUD | 75.36% |
| 2019 | 9.02 Million AUD | 65.51% |
| 2018 | 5.45 Million AUD | 10.24% |
| 2017 | 4.94 Million AUD | 352.8% |
| 2016 | 1.09 Million AUD | 61.67% |
| 2015 | 675.64 Thousand AUD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q4 | 120.01 Million AUD | 0.0% |
| 2024 Q1 | 143.73 Million AUD | 54.68% |
| 2024 Q2 | 143.73 Million AUD | 0.0% |
| 2024 Q3 | 120.01 Million AUD | -16.5% |
| 2024 FY | 120.01 Million AUD | 29.16% |
| 2023 Q3 | 92.92 Million AUD | 41.87% |
| 2023 FY | 92.92 Million AUD | 25.04% |
| 2023 Q4 | 92.92 Million AUD | 0.0% |
| 2023 Q2 | 65.5 Million AUD | 0.0% |
| 2023 Q1 | 65.5 Million AUD | -11.86% |
| 2022 Q1 | 77.36 Million AUD | -16.48% |
| 2022 FY | 74.31 Million AUD | -19.78% |
| 2022 Q4 | 74.31 Million AUD | 0.0% |
| 2022 Q3 | 74.31 Million AUD | -3.95% |
| 2022 Q2 | 77.36 Million AUD | 0.0% |
| 2021 FY | 92.63 Million AUD | 485.4% |
| 2021 Q2 | 51.27 Million AUD | 0.0% |
| 2021 Q1 | 51.27 Million AUD | 224.01% |
| 2021 Q3 | 92.63 Million AUD | 80.67% |
| 2021 Q4 | 92.63 Million AUD | 0.0% |
| 2020 Q4 | 15.82 Million AUD | 0.0% |
| 2020 Q1 | 21.44 Million AUD | 137.69% |
| 2020 FY | 15.82 Million AUD | 75.36% |
| 2020 Q2 | 21.44 Million AUD | 0.0% |
| 2020 Q3 | 15.82 Million AUD | -26.23% |
| 2019 FY | 9.02 Million AUD | 65.51% |
| 2019 Q4 | 9.02 Million AUD | 0.0% |
| 2019 Q3 | 9.02 Million AUD | 0.0% |
| 2019 Q1 | - AUD | 0.0% |
| 2018 FY | 5.45 Million AUD | 10.24% |
| 2017 FY | 4.94 Million AUD | 352.8% |
| 2016 FY | 1.09 Million AUD | 61.67% |
| 2015 FY | 675.64 Thousand AUD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Adherium Limited | 9.88 Million AUD | -1113.852% |
| Aroa Biosurgery Limited | 101.82 Million AUD | -17.868% |
| Atomo Diagnostics Limited | 11.37 Million AUD | -954.709% |
| Anteris Technologies Ltd | 45.7 Million AUD | -162.608% |
| Control Bionics Limited | 9.02 Million AUD | -1229.471% |
| CardieX Limited | 12.64 Million AUD | -848.754% |
| Compumedics Limited | 40.35 Million AUD | -197.377% |
| Cochlear Limited | 2.74 Billion AUD | 95.628% |
| CleanSpace Holdings Limited | 26.05 Million AUD | -360.681% |
| Cyclopharm Limited | 45.91 Million AUD | -161.391% |
| EMVision Medical Devices Ltd | 23.97 Million AUD | -400.661% |
| Nova Eye Medical Limited | 29.88 Million AUD | -301.631% |
| HeraMED Limited | 2.95 Million AUD | -3965.436% |
| Imricor Medical Systems, Inc. | 12.17 Million AUD | -885.669% |
| ImpediMed Limited | 46.98 Million AUD | -155.428% |
| InhaleRx Limited | 1.57 Million AUD | -7510.924% |
| LBT Innovations Limited | 7.93 Million AUD | -1413.245% |
| Micro-X Limited | 26.89 Million AUD | -346.237% |
| Neurotech International Limited | 12.21 Million AUD | -882.655% |
| OncoSil Medical Limited | 6.71 Million AUD | -1686.369% |
| PolyNovo Limited | 109.16 Million AUD | -9.937% |
| Respiri Limited | 6.19 Million AUD | -1838.573% |
| SomnoMed Limited | 69.8 Million AUD | -71.93% |
| Universal Biosensors, Inc. | 30.12 Million AUD | -298.453% |
| Uscom Limited | 5.13 Million AUD | -2237.375% |
| Visioneering Technologies, Inc. | 11.2 Million AUD | -971.05% |